1990
DOI: 10.1093/clinids/12.1.31
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness and Cost Benefit of a Proposed Live Cytomegalovirus Vaccine in the Prevention of Congenital Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

1993
1993
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(18 citation statements)
references
References 25 publications
0
18
0
Order By: Relevance
“…This is especially true for women who work in daycare settings and for those who are pregnant. [27][28][29][30][31][32][33] Limitations of this study The sample size was halved because of financial constraints. The authors preferred to detect anti-CMV IgG avidity to investigate recent acute infection and identify pregnant women at increased risk of having infected fetuses but could not due to financial constraints as well.…”
Section: Discussionmentioning
confidence: 99%
“…This is especially true for women who work in daycare settings and for those who are pregnant. [27][28][29][30][31][32][33] Limitations of this study The sample size was halved because of financial constraints. The authors preferred to detect anti-CMV IgG avidity to investigate recent acute infection and identify pregnant women at increased risk of having infected fetuses but could not due to financial constraints as well.…”
Section: Discussionmentioning
confidence: 99%
“…In our study, only 20% of the children belonged to the non-genetic causes. No figures are available as yet for the incidence or prevalence of cytomegalovirus (CMV) in general population in Oman but many countries report a high prevalence [14,[21][22][23]. This is a thrust area for further research and study in Oman.…”
Section: Discussionmentioning
confidence: 99%
“…The cost-effectiveness of both passive and active immunization using HIG against CMV has been formally estimated in four studies and was cost-effective in each study [39][40][41]42 ]. Two cost/benefit studies have addressed universal CMV screening of pregnant women and passive immunization with HIG [41,42 ].…”
Section: Therapy For Pregnant Women With a Primary Infectionmentioning
confidence: 99%